Decorin and TGF-β1 polymorphisms and development of COPD in a general population

Respiratory Research

Volumn 7, Issue , 2006, Pages

  van Diemen, Cleo C ^a   Postma, Dirkje S ^a   Vonk, Judith M ^a   Bruinenberg, Marcel ^a   Nolte, Ilja M ^a   Boezen, H Marike ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DECORIN; LEUCINE; PROLINE; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE; DCN PROTEIN, HUMAN; SCLEROPROTEIN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; INTRON; LUNG FUNCTION; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PREVALENCE; PROTEIN EXPRESSION; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGICAL MODEL; COMPARATIVE STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; NETHERLANDS; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RETROSPECTIVE STUDY;

DECORIN; EXTRACELLULAR MATRIX PROTEINS; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MODELS, GENETIC; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTEOGLYCANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33747114663     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-89     Document Type: Article

References (28)

1. Kokturk N, Tatlicioglu T, Memis L, Akyurek N, Akyol G: Expression of transforming growth factor beta1 in bronchial biopsies in asthma and COPD. J Asthma 2003, 40:887-893.
2. de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, van Krieken JH: Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158:1951-1957.
3. Pons AR, Sauleda J, Noguera A, Pons J, Barcelo B, Fuster A, Agusti AG: Decreased macrophage release of TGF-{beta} and TIMP-1 in chronic obstructive pulmonary disease. Eur Respir J 2005, 26:60-66.
4. Svensson L, Heinegard D, Oldberg A: Decorin-binding sites for collagen type 1 are mainly located in leucine-rich repeats 4-5. J BIOL CHEM 1995, 270:20712-20716.
5. Schonherr E, Hausser H, Beavan L, Kresse H: Decorin-type 1 collagen interaction. Presence of separate core protein-binding domains. J BIOL CHEM 1995, 270:8877-8883.
6. Bhide VM, Laschinger CA, Arora PD, Lee W, Hakkinen L, Larjava H, Sodek J, McCulloch CA: Collagen phagocytosis by fibroblasts is regulated by decorin. J BIOL CHEM 2005, 280:23103-23113.
7. Iozzo RV, Murdoch AD: Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 1996, 10:598-614.
8. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-beta by the proteoglycan decorin. NATURE 1990, 346:281-284.
9. Noordhoek JA, Postma DS, Chong LL, Menkema L, Kauffman HF, Timens W, Straaten JFM, Van der Geld YM: Different modulation of decorin production by lung fibroblasts from patients with mild and severe emphysema. COPD: Journal of Chronic Obstructive Pulmonary Disease 2005, 2:17-25.
10. van Straaten JF, Coers W, Noordhoek JA, Huitema S, Flipsen JT, Kauffman HF, Timens W, Postma DS: Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol 1999, 12:697-705.
11. Rijcken B, Schouten JP, Mensinga TT, Weiss ST, De Vries K, Van der Lende R: Factors associated with bronchial responsiveness to histamine in a population sample of adults. Am Rev Respir Dis 1993, 147:1447-1453.
12. Van der Lende R, Kok T, Peset R, Quanjer PH, Schouten JP, Orie NG: Longterm exposure to air pollution and decline in VC and FEV1. Recent results from a longitudinal epidemiologic study in the Netherlands. Chest 1981, 80:23-26.
13. Van der Lende R, Orie NG: The MRC-ECCS questionnaire on respiratory symptoms (use in epidemiology). Scand J. Respir Dis 1972, 53:218-226.
14. Celedon JC, Lange C, Raby BA, Litonjua AA, Palmer LJ, DeMeo DL, Reilly JJ, Kwiatkowski DJ, Chapman HA, Laird N, Sylvia JS, Hernandez M, Speizer FE, Weiss ST, Silverman EK: The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet 2004, 13:1649-1656.
15. Su ZG, Wen FQ, Feng YL, Xiao M, Wu XL: Transforming growth factor-beta1 gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population. Acta Pharmacol Sin 2005, 26:714-720.
16. Wu L, Chau J, Young RP, Pokorny V, Mills GD, Hopkins R, McLean L, Black PN: Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004, 59:126-129.
17. The International HapMap Project. NATURE 2003, 426:789-796.
18. Fabbri LM, Hurd SS: Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J 2003, 22:1-2.
19. CC D, DS P, JM V, M B, JP S, HM B: A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005, 172:329-333.
20. Pinheiro JC, Bates DM: Mixed-Effects Models in S and S-Plus New York, NY, Springer; 2000.
21. Rijcken B, Weiss ST: Longitudinal analyses of airway responsiveness and pulmonary function decline. Am J Respir Crit Care Med 1996, 154:S246-S249.
22. Team RC: R: A language and environment for statistical computing 2004 [http://www.R-project.org]. Vienna, Austria, R Foundation for Statistical Computing
23. Silverman ES, Palmer LJ, Subramaniam V, Hallock A, Mathew S, Vallone J, Faffe DS, Shikanai T, Raby BA, Weiss ST, Shore SA: Transforming Growth Factor-< beta >1 Promoter Polymorphism C-509T Is Associated with Asthma. AM J RESPIR CRIT CARE MED 2004; 169:2-219.
24. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L: Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998, 158:1958-1962.
25. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD: Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999, 8:93-97.
26. Awad MR, El Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV: Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998, 66:1014-1020.
27. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y: Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 1997, 322 (Pt 3):809-814.
28. Haj Zen A, Lafont A, Durand E, Brasselet C, Lemarchand P, Godeau G, Gogly B: Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts. Matrix Biol 2003, 22:251-258.